Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nørgaard-Pedersen

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1992
Prenatal and neonatal screening: status and future trendsB Nørgaard-Pedersen
Clinical Genetics|July 1, 1994
Towards acceptable practices for antenatal and neonatal screening for disease or disease riskB Nørgaard-Pedersen
Deutsche Medizinische Wochenschrift (1946)|March 9, 1979
[Clinical use of AFP and HCG in germ cell tumors of testis]B Nørgaard-Pedersen
Ugeskrift for Laeger|May 26, 1998
[The PKU registry and biobank at the National Serum Institute. Rules and applications]B Nørgaard-Pedersen
Ugeskrift for Laeger|February 10, 1986
[Serum alpha fetoprotein screening]B Nørgaard Pedersen
Lakartidningen|March 22, 1995
[Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against]U Kristoffersson, B Nørgaard-Pedersen
Clinical Genetics|June 15, 2005
Inhibin A is a maternal serum marker for Down's syndrome early in the first trimesterM Christiansen, B Nørgaard-Pedersen
Clinical Chemistry|October 1, 1986
Immunofluorometry of thyrotropin, from whole-blood spots on filter paper, to screen for congenital hypothyroidismJ Arends, B Nørgaard-Pedersen
Ugeskrift for Laeger|February 12, 1998
[Maternal serum screening for Down syndrome]B Nørgaard-Pedersen, M Christiansen
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
Biological specimen banks in neonatal screeningB Nørgaard-Pedersen, H Simonsen
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1992
Prenatal and neonatal screening: status and future trendsB Nørgaard-Pedersen
Clinical Genetics|July 1, 1994
Towards acceptable practices for antenatal and neonatal screening for disease or disease riskB Nørgaard-Pedersen
Deutsche Medizinische Wochenschrift (1946)|March 9, 1979
[Clinical use of AFP and HCG in germ cell tumors of testis]B Nørgaard-Pedersen
Ugeskrift for Laeger|May 26, 1998
[The PKU registry and biobank at the National Serum Institute. Rules and applications]B Nørgaard-Pedersen
Ugeskrift for Laeger|February 10, 1986
[Serum alpha fetoprotein screening]B Nørgaard Pedersen
Lakartidningen|March 22, 1995
[Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against]U Kristoffersson, B Nørgaard-Pedersen
Clinical Genetics|June 15, 2005
Inhibin A is a maternal serum marker for Down's syndrome early in the first trimesterM Christiansen, B Nørgaard-Pedersen
Clinical Chemistry|October 1, 1986
Immunofluorometry of thyrotropin, from whole-blood spots on filter paper, to screen for congenital hypothyroidismJ Arends, B Nørgaard-Pedersen
Ugeskrift for Laeger|February 12, 1998
[Maternal serum screening for Down syndrome]B Nørgaard-Pedersen, M Christiansen
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
Biological specimen banks in neonatal screeningB Nørgaard-Pedersen, H Simonsen
Pageof 14